Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia


Por: Fuster JL, Bautista F, González B, Fernández JM, Rives-Solà S and Dapena JL

Publicada: 1 sep 2021 Ahead of Print: 1 mar 2021
Resumen:


Filiaciones:
Fuster JL:
 Pediatric Oncology and Hematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Ctra. Madrid-Cartagena s/n, El Palmar, 30120, Murcia, Spain.

Bautista F:
 Pediatric Oncology, Hematology and Stem Cell Transplantation Department, Hospital Niño Jesús, Madrid, Spain

González B:
 Pediatric Oncology and Hematology Department, Hospital Universitario La Paz, Madrid, Spain

Fernández JM:
 Pediatric Oncology and Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Rives-Solà S:
 Pediatric Hematology and Oncology Department, Hospital San Joan de Déu, Institut de Recerca San Joan de Déu, Barcelona, Spain

Dapena JL:
 Pediatric Hematology and Oncology Department, Hospital San Joan de Déu, Institut de Recerca San Joan de Déu, Barcelona, Spain
ISSN: 1699048X





Clinical & Translational Oncology
Editorial
SPRINGER INT PUBL AG, GEWERBESTRASSE 11, CHAM CH-6330, SWITZERLAND, España
Tipo de documento: Letter
Volumen: 23 Número: 9
Páginas: 1963-1966
WOS Id: 000630612700001
ID de PubMed: 33742341

MÉTRICAS